Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Apply
Zanzalintinib & Pembrolizumab
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step